Katherine Volpe, MD
Urology · Campbell
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 36
- 10 carriers
- Offices
- 7
Offices
7 locations · Bay Area Gynecology Oncology Inc · Hazel Hawkins Memorial Hospital · County of Monterey
Looking this up.
Hospitals listed: El Camino Health · Good Samaritan Hospital · Natividad Medical Center. That is not proof they admit you there this week.
Plans that list them
36 plans · 10 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Volpe’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
36 of 36 plans
| Advantage Care (HMO) | Align Senior Care | Listed | Oct 1, 2026 |
| Premier Care (HMO I-SNP) | Align Senior Care | Listed | Oct 1, 2026 |
| Senior Care (HMO I-SNP) | Align Senior Care | Listed | Oct 1, 2026 |
| Alignment Health Advantage PPO (PPO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Prime (HMO-POS) | Anthem Blue Cross Partnership Plan | Listed | Oct 3, 2026 |
| Astiva Health C-SNP WOW - NorCal (HMO C-SNP) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Premier Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Savings Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Blue Shield Inspire (HMO) | Blue Shield of California | Listed | Aug 26, 2026 |
| Central Health Classic Care Plan III (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Dual Access Plan (HMO D-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Embrace Care Plan (HMO C-SNP) | Central Health Medicare Plan | Listed, may be out of date | Sep 15, 2025 |
| Central Health Embrace Choice Plan (HMO C-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Valor Care Plan (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A147847 · Current
Licensed to practise in California · since 2017 · expires 2028-05-31 · Oregon Health & Science University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
3 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- El Camino HealthMountain View, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of El Camino Health, which runs 2 hospitalsPatients rate it 4 of 5 · 80% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.291, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.393, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0, Oct 2024 – Sep 2025
- Good Samaritan HospitalSan Jose, CAAcute Care Hospital · Proprietary · Has an emergency department · Birthing-friendlyPart of HCA Healthcare, which runs 185 hospitals in 19 statesPatients rate it 2 of 5 · 67% would definitely recommend itOverall rating: 2 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.337, Oct 2024 – Sep 2025
- Natividad Medical CenterSalinas, CAAcute Care Hospital · Government - Local · Has an emergency department · Birthing-friendlyPart of Natividad Medical CenterPatients rate it 3 of 5 · 71% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.316, Oct 2024 – Sep 2025
See every measure and the patient survey for El Camino Health
Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.291 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.393 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.96 (0.12 to 1.79) · 2,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.76 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 167.38 (125.03 to 209.73) · 96 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 68 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 185 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 814 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13 · 842 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 361 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.6 · 4,633 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.34) · 11,474 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.1 to 0.45) · 11,626 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.14 (1.39 to 4.9) · 2,814 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2 (0.61 to 3.39) · 1,327 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.8 to 3.43) · 2,641 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.39 (4.18 to 14.6) · 1,287 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.57 (3.47 to 9.68) · 1,308 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.14 (0.71 to 3.57) · 827 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.6 (0.05 to 1.15) · 9,460 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.5 · 122 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.993 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.706 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.376 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.5 · 218 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.5 · 962 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 3.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -17 · 922 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 18.6 · 860 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.7 · 827 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.1 (4.5 to 8.2) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.4 (10.6 to 16.5) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.7 · 237 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.8 (10 to 16.1) · 1,639 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.8 to 1.1) · 1,619 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,535 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 47% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for Good Samaritan Hospital
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 1 worse of 8 measures. Readmissions: 0 better, 5 the same, 4 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.337 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.75 (0 to 1.67) · 1,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.84 (0.54 to 1.14) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 143.59 (98.7 to 188.49) · 98 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.7 · 45 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 100 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.7 · 270 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.3 · 573 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.6 · 820 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.5 · 482 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.3 · 3,711 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.12 (0 to 0.3) · 8,866 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.2 (0.01 to 0.38) · 9,051 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.65 (0.74 to 4.56) · 1,929 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.8 (0.21 to 3.39) · 670 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.33 (0.88 to 3.78) · 1,836 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 6.73 (0 to 13.46) · 669 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.58 (3.96 to 11.19) · 654 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.59 (0.13 to 3.04) · 496 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.27 (0 to 0.87) · 7,373 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.1 · 152 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 1.08 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.542 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.484 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.565 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.8 · 327 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 24.2 · 703 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 61.1 · 289 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 36.3 · 665 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 25.4 · 856 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 19 · 978 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.3 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 12.3 · 46 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 21.2 · 135 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.8 (10.1 to 18.6) · 129 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.2 (0.9 to 1.5) · 531 cases | No different | Jan 2024 – Dec 2024 |
What patients said (704 patients answered, 24% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 2 |
| Quietness | 1 |
| Recommend hospital | 3 |
| Room was "always" clean | 66% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 71% |
| Staff "always" explained | 54% |
| Yes, staff "did" give patients this information | 83% |
| Yes, staff "did" give patients information about help after discharge | 81% |
| Doctors "always" explained things so they could understand | 66% |
| Doctors "always" listened carefully | 69% |
| Doctors "always" treated them with courtesy and respect | 78% |
| Patients who gave a rating of "9" or "10" (high) | 63% |
| Staff "always" explained new medications | 68% |
| Nurses "always" explained things so they could understand | 69% |
| Nurses "always" listened carefully | 73% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 38% |
| "YES", patients would definitely recommend the hospital | 67% |
| Staff "always" explained possible side effects | 40% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for Natividad Medical Center
Behind the star rating — Deaths: 0 better, 6 the same, 0 worse of 6 measures. Safety: 1 better, 5 the same, 0 worse of 6 measures. Readmissions: 0 better, 6 the same, 0 worse of 6 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.316 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.98 (0 to 2.04) · 332 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.18 (0.76 to 1.6) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 165.77 (109.76 to 221.78) · 28 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 9.9 · 47 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.5 · 80 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 18.4 · 110 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 11.5 · 34 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 4.4 · 609 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.26 (0.03 to 0.48) · 2,445 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.25 (0.04 to 0.46) · 2,213 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.36 (2.03 to 6.7) · 564 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.64 (0 to 3.36) · 79 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.08 (0.44 to 3.71) · 555 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 10.67 (1.19 to 20.15) · 87 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.92 (0.71 to 9.12) · 79 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.73 (0.21 to 3.24) · 81 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 1.07 (0.12 to 2.02) · 1,742 cases | No different | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.462 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.9 · 62 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 8.4 · 93 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -7.3 · 121 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.1 · 100 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.3 · 32 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13 (9.7 to 17.9) · 162 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.1 (0.7 to 1.5) · 72 cases | No different | Jan 2024 – Dec 2024 |
What patients said (966 patients answered, 55% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 74% |
| Doctors "always" communicated well | 78% |
| Staff "always" explained | 60% |
| Yes, staff "did" give patients this information | 85% |
| Yes, staff "did" give patients information about help after discharge | 83% |
| Doctors "always" explained things so they could understand | 73% |
| Doctors "always" listened carefully | 77% |
| Doctors "always" treated them with courtesy and respect | 83% |
| Patients who gave a rating of "9" or "10" (high) | 72% |
| Staff "always" explained new medications | 74% |
| Nurses "always" explained things so they could understand | 70% |
| Nurses "always" listened carefully | 72% |
| Nurses "always" treated them with courtesy and respect | 81% |
| "Always" quiet at night | 37% |
| "YES", patients would definitely recommend the hospital | 71% |
| Staff "always" explained possible side effects | 45% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
Original Medicare doctor bills
$222,275
Medicare paid this office $222,275 for 337 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 150 | $30,131 | $116 |
| New patient visit (45+ min) | 141 | $21,526 | $153 |
| Short return visit (20+ min) | 138 | $18,736 | $81 |
| Complex measurement of pressure of urine flow in bladder with urethra pressure and voiding pressure studies | 45 | $17,970 | $391 |
| Long return visit (40+ min) | 45 | $11,646 | $166 |
See all 22 services
| Return visit (30+ min) | 150 | $30,131 | $116 |
| New patient visit (45+ min) | 141 | $21,526 | $153 |
| Short return visit (20+ min) | 138 | $18,736 | $81 |
| Complex measurement of pressure of urine flow in bladder with urethra pressure and voiding pressure studies | 45 | $17,970 | $391 |
| Long return visit (40+ min) | 45 | $11,646 | $166 |
| Surgical repair of vaginal defect using an endoscope | 13 | $10,022 | $771 |
| Insertion of temporary bladder tube | 196 | $9,542 | $43 |
| Insertion of device into abdomen with pressure and urine flow rate study | 45 | $9,329 | $203 |
| Creation of sling around urethra in female to control leakage | 20 | $8,791 | $440 |
| Pelvic exam | 251 | $8,373 | $25 |
| New patient visit (60+ min) | 40 | $8,160 | $204 |
| Repair of herniated rectum into vaginal wall | 16 | $4,719 | $295 |
| Diagnostic exam of bladder and urethra using an endoscope | 13 | $3,312 | $237 |
| Short return visit | 41 | $2,627 | $54 |
| Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings | 45 | $1,460 | $32 |
| Short return visit (20+ min) | 17 | $1,179 | $44 |
| Fitting and insertion of vaginal support device | 13 | $1,082 | $72 |
| Return visit (30+ min) | 12 | $940 | $72 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 31 | $598 | $15 |
| Electronic assessment of bladder emptying | 54 | $401 | $7 |
| Pelvic exam | 12 | $215 | $17 |
| Insertion of temporary bladder tube | 13 | $183 | $14 |
Procedures Medicare counted
| Removal of skin lesions | 1-10 | None |
| Removal of the uterus | 22 | More than 94% of doctors who do this |
Who their Medicare patients are
337 Original Medicare patients in 2024. Average age 75 · Under 65 3% · 85 and older 15% · Also on Medicaid 20% · Health risk score 1.04. Above the middle of the specialty; the typical obstetrics & gynecology clinician is at 0.88.
Conditions among them: High blood pressure 73% · Diabetes 28% · Coronary heart disease 19% · Chronic kidney disease 19% · Depression 19% · Cancer 15% · Atrial fibrillation 12% · Heart failure 11% · COPD 10% · Stroke 10% · Dementia 9%.
The office billed $1,027,074, Medicare allowed $286,928 and paid $222,275; for 2,288 services of 82 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 337 | 2,288 | 75 | 1.04 | $1,027,074 | $222,275 |
| 2023 | 262 | 1,676 | 75 | 1.00 | $938,634 | $173,367 |
| 2022 | 225 | 1,224 | 74 | 1.02 | $597,320 | $137,627 |
| 2021 | 158 | 984 | 73 | 1.18 | $577,779 | $135,570 |
| 2020 | 17 | 45 | 74 | 1.07 | $17,921 | $4,459 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 18 services
| Complex measurement of pressure of urine flow in bladder with urethra pressure and voiding pressure studies | 50 | $20,462 | $401 |
| Short return visit (20+ min) | 117 | $18,327 | $83 |
| Return visit (30+ min) | 78 | $13,115 | $117 |
| Creation of sling around urethra in female to control leakage | 26 | $11,986 | $461 |
| New patient visit (45+ min) | 78 | $11,327 | $145 |
| Insertion of device into abdomen with pressure and urine flow rate study | 50 | $10,590 | $208 |
| Surgical repair of vaginal defect using an endoscope | 13 | $9,435 | $726 |
| New patient visit (60+ min) | 40 | $7,591 | $190 |
| Long return visit (40+ min) | 33 | $6,774 | $169 |
| Insertion of temporary bladder tube | 118 | $5,687 | $43 |
| Short return visit | 59 | $3,723 | $49 |
| Repair of herniated rectum into vaginal wall | 11 | $3,092 | $281 |
| Diagnostic exam of bladder and urethra using an endoscope | 12 | $2,778 | $232 |
| Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings | 50 | $1,612 | $32 |
| New patient visit (30+ min) | 15 | $1,604 | $107 |
| Short return visit (20+ min) | 18 | $1,394 | $52 |
| Electronic assessment of bladder emptying | 70 | $669 | $8 |
| Insertion of temporary bladder tube | 14 | $326 | $19 |
2022: 17 services
| New patient visit (60+ min) | 83 | $15,918 | $192 |
| Complex measurement of pressure of urine flow in bladder with urethra pressure and voiding pressure studies | 34 | $14,056 | $413 |
| Short return visit (20+ min) | 96 | $13,996 | $80 |
| Return visit (30+ min) | 63 | $9,169 | $115 |
| Plastic repair of vagina and tissue separating vagina, rectum, and bladder | 12 | $7,947 | $662 |
| Insertion of device into abdomen with pressure and urine flow rate study | 36 | $7,745 | $215 |
| Short return visit | 87 | $5,989 | $48 |
| Insertion of temporary bladder tube | 109 | $5,416 | $44 |
| Repair of pelvic ligaments through vagina | 14 | $4,847 | $346 |
| New patient visit (45+ min) | 30 | $4,732 | $158 |
| Long return visit (40+ min) | 23 | $4,656 | $166 |
| Fitting and insertion of vaginal support device | 24 | $1,775 | $63 |
| Long return visit (40+ min) | 12 | $1,447 | $103 |
| Pessary, reusable, non rubber, any type | 22 | $1,207 | $43 |
| Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings | 36 | $1,143 | $32 |
| Return visit (30+ min) | 14 | $1,082 | $68 |
| Electronic assessment of bladder emptying | 45 | $361 | $7 |
2021: 16 services
| Short return visit (20+ min) | 77 | $14,265 | $90 |
| New patient visit (60+ min) | 68 | $13,373 | $197 |
| Return visit (30+ min) | 54 | $13,283 | $123 |
| Complex measurement of pressure of urine flow in bladder with urethra pressure and voiding pressure studies | 30 | $13,085 | $422 |
| Long return visit (40+ min) | 43 | $9,334 | $173 |
| Insertion of device into abdomen with pressure and urine flow rate study | 29 | $6,240 | $208 |
| Repair of pelvic ligaments through vagina | 11 | $3,640 | $331 |
| Insertion of temporary bladder tube | 46 | $2,735 | $46 |
| Fitting and insertion of vaginal support device | 25 | $2,603 | $70 |
| Short return visit | 34 | $2,356 | $56 |
| New patient visit (45+ min) | 13 | $1,804 | $139 |
| New patient visit (60+ min) | 11 | $1,380 | $125 |
| Pessary, reusable, non rubber, any type | 19 | $1,342 | $46 |
| Irrigation of vagina and/or application of drug to treat infection | 14 | $1,247 | $59 |
| Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings | 30 | $1,047 | $34 |
| Electronic assessment of bladder emptying | 67 | $818 | $9 |
Medicaid work
$3 in 2024
Medicaid paid $3 for 13 billed services this clinician did in 2024, up to 12 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| PELVIC EXAMINATION | 13 | $3 |
| 2024 | 13 | 1 | 12 | $3 |
| 2022 | 19 | 1 | 19 | $0 |
See the largest Medicaid services in earlier years
2022
| Provision of test materials and equipment for home inr monitoring of patient with either mechanical heart valve(s), chronic atrial fibrillation, or venous thromboembolism who meets medicare coverage criteria; includes: provision of materials for use in the home and reporting of test results to physician; testing not occurring more frequently than once a week; testing materials, billing units of service include 4 tests | 19 | $0 |
Drugs they prescribed that Part D paid
$340,671
Pharmacies billed $340,671 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 2% of their Part D prescriptions (14 of 927) in 2024. Above the middle of the specialty; the typical obstetrics & gynecology clinician is at 0%.
494 generic and 433 brand-name prescriptions · $340,671 in drug cost · 96 antibiotic prescriptions to 44 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Gemtesa | 368 | $279,258 | $759 |
| Myrbetriq | 30 | $23,550 | $785 |
| Estradiol | 268 | $17,661 | $66 |
| Estring | 15 | $8,158 | $544 |
| Yuvafem | 17 | $2,065 | $121 |
See all 10 drugs
| Gemtesa | 368 | $279,258 | $759 |
| Myrbetriq | 30 | $23,550 | $785 |
| Estradiol | 268 | $17,661 | $66 |
| Estring | 15 | $8,158 | $544 |
| Yuvafem | 17 | $2,065 | $121 |
| Clobetasol Propionate | 29 | $553 | $19 |
| Loperamide | 18 | $207 | $12 |
| Nitrofurantoin Mono-Macro | 17 | $180 | $11 |
| Sulfamethoxazole-Trimethoprim | 33 | $168 | $5 |
| Ciprofloxacin | 12 | $79 | $7 |
Year by year
| 2024 | 927 | 281 | 2% (14) | 47% | $340,671 |
| 2023 | 686 | 207 | 2% (14) | 46% | $234,801 |
| 2022 | 597 | 175 | 4% (25) | 35% | $122,610 |
| 2021 | 321 | 104 | 6% (20) | 25% | $44,569 |
| 2020 | 75 | 22 | 0% (0) | 41% | $19,915 |
| 2019 | 87 | 45 | 17% (15) | 37% | $12,745 |
| 2018 | 26 | 17 | None | 42% | $2,449 |
| 2017 | 24 | None | 0% (0) | 71% | $1,021 |
| 2016 | 28 | 13 | None | None | $1,289 |
| 2015 | 64 | 32 | None | None | $4,487 |
| 2014 | 62 | 26 | None | None | $2,719 |
| 2013 | 22 | 13 | None | None | $1,166 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 10 drugs
| Gemtesa | 248 | $167,487 | $675 |
| Estradiol | 183 | $22,691 | $124 |
| Myrbetriq | 34 | $21,192 | $623 |
| Estring | 14 | $7,844 | $560 |
| Premarin | 13 | $6,108 | $470 |
| Yuvafem | 18 | $1,918 | $107 |
| Fosfomycin Tromethamine | 13 | $1,351 | $104 |
| Clobetasol Propionate | 18 | $689 | $38 |
| Sulfamethoxazole-Trimethoprim | 27 | $230 | $9 |
| Ciprofloxacin | 11 | $135 | $12 |
2022: 10 drugs
| Gemtesa | 121 | $63,590 | $526 |
| Estradiol | 181 | $21,088 | $117 |
| Myrbetriq | 38 | $17,097 | $450 |
| Estring | 11 | $5,699 | $518 |
| Yuvafem | 36 | $5,379 | $149 |
| Methenamine Hippurate | 20 | $2,042 | $102 |
| Diclofenac | 29 | $151 | $5 |
| Sulfamethoxazole-Trimethoprim | 26 | $121 | $5 |
| Tramadol | 24 | $73 | $3 |
| Ciprofloxacin | 14 | $70 | $5 |
2021: 8 drugs
| Estradiol | 79 | $9,918 | $126 |
| Gemtesa | 18 | $9,455 | $525 |
| Premarin | 17 | $7,320 | $431 |
| Myrbetriq | 15 | $6,534 | $436 |
| Yuvafem | 17 | $1,368 | $80 |
| Diclofenac | 18 | $91 | $5 |
| Sulfamethoxazole-Trimethoprim | 23 | $52 | $2 |
| Tramadol | 14 | $31 | $2 |
2020: 2 drugs
| Myrbetriq | 25 | $11,671 | $467 |
| Estradiol | 17 | $2,992 | $176 |
2019: 1 drug
| Myrbetriq | 18 | $6,789 | $377 |
2017: 1 drug
| Mononessa | 13 | $130 | $10 |
2014: 1 drug
| Sulfamethoxazole-Trimethoprim | 13 | $60 | $5 |
Money from drug and device companies
$779 in 2025
| 2025 | 12 | 28 | None | $779 |
| 2024 | 12 | 28 | None | $910 |
| 2023 | 12 | 29 | None | $1,414 |
| 2022 | 12 | 15 | None | $444 |
| 2021 | 9 | 13 | None | $1,419 |
| 2020 | 6 | 7 | None | $352 |
| 2019 | 3 | 7 | None | $665 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Sumitomo Pharma America | Gemtesa | $266 | 10 payments
|
| Smith+Nephew | Stravix | $96 | 2 payments
|
| Astellas Pharma US | Veozah | $87 | 3 payments
|
| Abbvie | Botox | $83 | 3 payments
|
| Bluewind Medical | Revi | $82 | 3 payments
|
| Minerva Surgical | None | $36 | 1 payment
|
See all 28 published payments
| Abbvie | Meals · 2025-12-16 | Botox | $22 |
| Sumitomo Pharma America | Meals · 2025-12-08 | Gemtesa | $39 |
| Astellas Pharma US | Meals · 2025-11-19 | Veozah | $26 |
| Sumitomo Pharma America | Meals · 2025-11-04 | Gemtesa | $27 |
| Sumitomo Pharma America | Meals · 2025-11-03 | Gemtesa | $2 |
| Smith+Nephew | Meals · 2025-09-16 | Stravix | $48 |
| Integra LifeSciences | Meals · 2025-09-09 | Codman Certas | $18 |
| Bluewind Medical | Meals · 2025-08-19 | Revi | $29 |
| Astellas Pharma US | Meals · 2025-08-13 | Veozah | $29 |
| Sumitomo Pharma America | Meals · 2025-08-07 | Gemtesa | $36 |
| Abbvie | Meals · 2025-08-07 | Botox | $32 |
| Smith+Nephew | Meals · 2025-07-30 | Stravix | $48 |
| Sumitomo Pharma America | Meals · 2025-07-09 | Gemtesa | $37 |
| Sumitomo Pharma America | Meals · 2025-07-08 | Gemtesa | $13 |
| Coloplast | Meals · 2025-07-03 | Altis | $14 |
| Bluewind Medical | Meals · 2025-06-04 | Revi | $25 |
| Vertex Pharmaceuticals | Meals · 2025-04-29 | Journavx | $25 |
| Sumitomo Pharma America | Meals · 2025-04-24 | Gemtesa | $31 |
| Bluewind Medical | Meals · 2025-04-23 | Revi | $28 |
| Biotissue Holdings | Meals · 2025-04-17 | None | $18 |
| Ethicon US | Meals · 2025-04-16 | Surgiflo Hemostatic Matrix | $34 |
| Minerva Surgical | Meals · 2025-04-16 | None | $36 |
| Astellas Pharma US | Meals · 2025-03-11 | Veozah | $32 |
| Sumitomo Pharma America | Meals · 2025-02-23 | Gemtesa | $37 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-02-11 | Lynparza | $21 |
| Sumitomo Pharma America | Meals · 2025-01-29 | Gemtesa | $36 |
| Sumitomo Pharma America | Meals · 2025-01-28 | Myfembree | $6 |
| Abbvie | Meals · 2025-01-16 | Botox | $29 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $910
| Sumitomo Pharma America | Gemtesa | $206 | 11 payments
|
| Astellas Pharma US | Veozah | $170 | 4 payments
|
| Abbvie | Botox | $129 | 2 payments
|
| Axonics | Axonics | $128 | 1 payment
|
| Ethicon US | Harmonic | $70 | 2 payments
|
| Medtronic | Interstim | $58 | 2 payments
|
| Intuitive Surgical | Da Vinci Surgical System | $40 | 1 payment
|
| Boston Scientific | Advantage System | $36 | 1 payment
|
| Dilon Technologies | Hemoblast Bellows | $29 | 1 payment
|
| Myriad Genetic Laboratories | Precisetumor | $20 | 1 payment
|
| Laborie Medical Technologies | Eclipse | $19 | 1 payment
|
| Meditrina | None | $6 | 1 payment
|
2023: $1,414
| Medtronic | Interstim | $405 | 7 payments
|
| Caldera Medical | Desara | $324 | 3 payments
|
| Sumitomo Pharma America | Gemtesa | $185 | 7 payments
|
| FEMSelect | Enplace | $146 | 2 payments
|
| Coloplast | Altis | $136 | 2 payments
|
| Ethicon US | Echelon Circular | $59 | 1 payment
|
| Myriad Genetic Laboratories | Mychoice Cdx | $51 | 2 payments
|
| Intuitive Surgical | Da Vinci Surgical System | $25 | 1 payment
|
| Biotissue Holdings | Neox | $23 | 1 payment
|
| Teleflex | Quikclot | $22 | 1 payment
|
| Boston Scientific | None | $21 | 1 payment
|
| Seagen | Tivdak | $17 | 1 payment
|
2022: $444
| Urovant Sciences | Gemtesa | $88 | 3 payments
|
| Coloplast | Altis | $68 | 1 payment
|
| Conmed | Abc Handpieces | $56 | 1 payment
|
| Caldera Medical | Desara | $40 | 1 payment
|
| Abbvie | Orilissa | $37 | 2 payments
|
| Seagen | Tivdak | $35 | 1 payment
|
| C. R. Bard Inc. & Subsidiaries | None | $29 | 1 payment
|
| Myovant Sciences | Myfembree | $23 | 1 payment
|
| Davol | Arista Ah Flexitip | $20 | 1 payment
|
| Axonics | Bulkamid | $18 | 1 payment
|
| Boston Scientific | Upsylon | $15 | 1 payment
|
| Clovis Oncology | Rubraca | $15 | 1 payment
|
2021: $1,419
| Intuitive Surgical | Da Vinci Surgical System | $1,029 | 2 payments
|
| Medtronic | Interstim | $146 | 2 payments
|
| Conmed | Airseal | $114 | 2 payments
|
| Myovant Sciences | Myfembree | $38 | 2 payments
|
| Urovant Sciences | Gemtesa | $25 | 1 payment
|
| Merck Sharp & Dohme | Keytruda | $20 | 1 payment
|
| Tissuetech | Neox | $19 | 1 payment
|
| Coloplast | Restorelle | $16 | 1 payment
|
| Clovis Oncology | Rubraca | $14 | 1 payment
|
2020: $352
| Conmed | Abc Handpieces | $150 | 2 payments
|
| Boston Scientific | Advantage Fit | $77 | 1 payment
|
| Medtronic USA | Interstim | $66 | 1 payment
|
| Baudax Bio | Anjeso | $23 | 1 payment
|
| Baxter Healthcare | Adept | $20 | 1 payment
|
| Davol | Progel | $16 | 1 payment
|
2019: $665
| Coloplast | Restorelle | $395 | 4 payments
|
| Boston Scientific | Solyx | $138 | 2 payments
|
| Medtronic USA | Interstim | $132 | 1 payment
|
Professional record
- NPI
- 1306102520
- Licence
- CA A147847, NM MD2016-0311California A147847: Current · expires 2028-05-31
- Trained
- Oregon Health Sciences University School of Medicine, 2012
- Group
- Bay Area Gynecology Oncology Inc · Hazel Hawkins Memorial Hospital · County of Monterey
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 2088F0040X (2088F0040X); Federal specialty code 207V00000X (207V00000X)
- Mailing address
- 455 Oconnor Dr Ste 370, San Jose, CA, 95128
- NPI first listed
- 2012-04-02
- NPI last updated
- 2020-11-06
- NPI record certified
- 2020-11-06
This is when the NPI record was last certified, not a medical board exam.